Search

Search results

About Unlock Genetics

The aim of the site is to increase the level of awareness and understanding of genetic testing and genetic counselling among people living with inherited retinal dystrophies, empowering them to make fully informed decisions about their lives, healthcare and family planning.

Autosomal dominant inheritance

Autosomal dominant inheritance means that the faulty gene is on an autosome (any chromosome other than the sex chromosomes) and that only one faulty copy is needed to cause sight loss.

Autosomal recessive inheritance

Autosomal recessive inheritance means that the faulty gene is on an autosome (any chromosome other than the sex chromosomes) and that both copies need to be faulty to cause sight loss

The text in graphic says: Eye care support pathway Supporting you at every stage of your journey Underneath a graphic shows the four stages of an individual’s journey with the following text: 1. Having my initial appointment 2. Waiting well 3. Having my diagnosis confirmed 4. Waiting well 5. Support after my diagnosis 6. Waiting well 7. Living well with my condition Underneath this graphic it outlines what an individual can expect on their journey. Understand my eye care journey Understand my diagnosis Access emotional and practical support

The Eye Care Support Pathway

The Eye Care Support Pathway is a new framework to ensure patients have timely access to information, advice and support throughout their eye care journey.

Medical Advisory Board

Our Medical Advisory Board (MAB) advises our Board of Trustees in order that they can approve grants for research projects.

Terms & Conditions

Please read our conditions of use carefully as by using the website you will be assumed to have agreed to be bound by them.

Jing Yu - a man wearing an orange t shirt facing the camera. There is a microscope to his left on a desk.

A blog from the research coal face

Jing Yu is a bioinformatician with the Eye Research Group at Oxford University, and is part of the UK Inherited Retinal Dystrophy Consortium (UKIRDC) team, funded by a Retina UK  grant.

Start your own fundraising

Organising your own fundraising is great fun and a brilliant way to involve your friends, family and local community.

ReNeuron trial FAQs

You may have heard that a cell-based treatment approach (sometimes referred to as a “stem cell treatment”), developed by a company called ReNeuron, is being tested in a clinical trial at Oxford Eye Hospital and other centres in the US and Europe.